Synchron
[PRIVATE]Service & Cobot Robotics · HQ: New York, NY · Est. 2016 · 1 model registered · 5 deployments
As of Sep 2026, DEPLOY verifies Synchron: 1 model, 5 deployments across 3 regions, $200.0M raised. 1 source back the record.
Ownership
PRIVATE
Capital / Funding
including a $200M Series D in 2024. Synchron's COMMAND and Switch clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
Headquarters
New York, NY
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and Switch clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
Clean safety record across 5 verified deployments. Broad public reach with 1.2M video views. Deployment footprint remains limited relative to category peers.
Key Facts
Safety & Regulatory Posture
No incidents on record for Synchron.
Leadership & Founders
Current Program Leadership & Executives
Founder & CEO
Founding Team
cofounder
Partnerships & Commercial Deployments
Operator Customers & Fleet Integrators
Platform Models
Deployments
- Synchron Stentrode at Pittsburgh, Pennsylvania, USA[OPERATIONAL]
Pittsburgh, Pennsylvania, USA · Oct 27, 2022
- Synchron Stentrode at Buffalo, New York, USA[OPERATIONAL]
Buffalo, New York, USA · Jan 1, 2023
- Synchron Stentrode at New York, New York, USA[OPERATIONAL]
New York, New York, USA · Jan 1, 2021
- Synchron Stentrode at Jacksonville, Florida, USA[OPERATIONAL]
Jacksonville, Florida, USA · Jan 1, 2021
- Synchron Stentrode at Melbourne, Victoria, Australia[OPERATIONAL]
Melbourne, Victoria, Australia · Jan 1, 2019
Sectors & Applications
FAQ
What is Synchron?
Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and Switch clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
What does Synchron make?
Synchron has 1 robot model on the DEPLOY registry: Synchron Stentrode (Synchron builds physical robots).
Is Synchron publicly traded?
No. Synchron is privately held and not publicly traded, per the DEPLOY registry.
Who competes with Synchron?
On the DEPLOY registry, peer companies to Synchron building in the same form factors include Earendil Robotics, Bee, Plaud AI, Xiaomi.
Who is the CEO of Synchron?
Tom Oxley is the ceo of Synchron, per the DEPLOY registry.
How can I invest in Synchron?
Synchron is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $200M in disclosed funding.
Where is Synchron headquartered?
Synchron is headquartered in New York, NY, USA.
How much funding has Synchron raised?
Synchron has raised approximately $200M in disclosed funding on record in the DEPLOY registry.
Who owns Synchron?
Synchron is privately held and venture-backed ($200M raised); ownership sits with its founders and private investors.
Where does Synchron operate robots?
Synchron operates 5 verified deployments, including at Pittsburgh, Pennsylvania, USA, Buffalo, New York, USA, New York, New York, USA.
How many robots has Synchron deployed?
DEPLOY has 5 verified Synchron deployments on record at sites including Pittsburgh, Pennsylvania, USA, Buffalo, New York, USA, New York, New York, USA. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is Synchron a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Synchron ranks in roughly the top 7% of companies tracked by the registry.
When was Synchron founded?
Synchron was founded in 2016.
Is Synchron safe?
Synchron has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.